OBJECTIVES: This study sought to analyze the effectiveness of cardiac resynchronization therapy (CRT) related to the viability in the segment of left ventricular (LV) lead position defined by myocardial deformation imaging. BACKGROUND: Echocardiographic myocardial deformation analysis allows determination of LV lead position as well as extent of @entity296 . METHODS: Myocardial deformation imaging based on tracking of acoustic markers within 2-dimensional echo images (GE Ultrasound, GE Healthcare, Horton, Norway) was performed in 65 @entity712 @entity1 (54    6 years of age, 41 @entity1 ) before and 12 months after CRT implantation. In a 16-segment model, the LV lead position was defined based on the segmental strain curve with earliest peak strain, whereas the CRT system was programmed to pure LV pacing. Nonviability of a segment (transmural scar formation) was assumed if the peak systolic circumferential strain was >-11.1%. RESULTS: In 47 @entity1 , the LV lead was placed in a viable segment, and in 18 @entity1 , it was placed in a nonviable segment. At 12-month follow-up there was greater decrease of LV end-diastolic volumes (58    13 ml vs. 44    12 ml, p = 0.0388) and greater increase of LV ejection fraction (11    4% vs. 5    4%, p = 0.0343) and peak @entity26 consumption (2.5    0.9 ml/kg/min vs. 1.7    1.1 ml/kg/min, p = 0.0465) in the viable compared with the nonviable group. The change in LV ejection fraction and the reduction in LV end-diastolic volumes at follow-up correlated to an increasing peak systolic circumferential strain in the segment of the LV pacing lead (r = 0.61, p = 0.0274 and r = 0.64, p = 0.0412, respectively). Considering only @entity1 with @entity741 , differences between viable and nonviable LV lead position group were even greater. CONCLUSIONS: Preserved viability in the segment of the CRT LV lead position results in greater LV reverse remodeling and functional benefit at 12-month follow-up. Deformation imaging allows analysis of viability in the LV lead segment.

Dependency of cardiac resynchronization therapy on XXXX at the LV lead position.

@entity1 :: ('9606', 'Species') :: ['patients', 'men'] @entity712 :: ('MESH:D006333', 'Disease') :: ['heart failure'] @entity296 :: ('MESH:D009202', 'Disease') :: ['myocardial viability'] @entity26 :: ('MESH:D010100', 'Chemical') :: ['oxygen'] @entity741 :: ('MESH:D017202', 'Disease') :: ['ischemic heart disease']
@entity296 :: (MESH:D009202,Disease) :: ['myocardial viability']
